Home > Boards > US OTC > Cannabis > North American Cannabis Holdings Inc. (USMJ)

No big investors will ever put any money

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Futures1 Member Profile
 
Followed By 0
Posts 4
Boards Moderated 0
Alias Born 10/30/17
160x600 placeholder
PURA Aims To Modestly Extract $10 Million This Year From $18 Billion Hemp Industry Establishing A Foothold In A Much Larger Opportunity InvestorsHub NewsWire - 1/19/2022 9:26:09 AM
PJET CEO Indicates Cryptocurrency Strategy In The Works InvestorsHub NewsWire - 12/10/2021 9:42:16 AM
PURA Farmersville Hemp Targets $13B CBD Market And $41B Sustainability Market InvestorsHub NewsWire - 12/6/2021 1:01:13 PM
PJET Student Housing Alternative To Launch As Student Housing Shortage Exacerbated By Covid Economic Impact InvestorsHub NewsWire - 11/8/2021 9:48:12 AM
PURA and PAOG Partner With UCASU in Cannabis Real Estate Deal InvestorsHub Cannabis NewsWire - 11/4/2021 9:02:36 AM
PJET Expands Short-Term Rental Market With SHBO App For College Students InvestorsHub NewsWire - 11/4/2021 8:54:40 AM
PJET Announces Brick and Mortar Student Housing Project To Complement App InvestorsHub NewsWire - 11/1/2021 2:10:18 PM
ALYI, PAOG, And WSGF Are Surging In October; Near Term Catalysts Make Them A Micro-Cap Power Play InvestorsHub NewsWire - 10/28/2021 1:37:33 PM
PURA Stock Closes Near Four Month Highs As Partnership With PAOG Accelerates Move Into Hemp And CBD Sectors InvestorsHub NewsWire - 10/21/2021 12:51:11 PM
PAOG Reveals CBD Products Under Development For $100 Billion Pet Market InvestorsHub NewsWire - 10/20/2021 10:01:17 AM
PAOG - PAO Group, Inc. Stock Gains 220% Since September; Announces Commercial Launch Of First CBD Nutraceuticals Product Through Partner USMJ InvestorsHub NewsWire - 10/19/2021 11:25:23 AM
PAOG To Launch Second CBD Nutraceutical Product Later This Week Further Ramping Up 2021 Revenue Potential InvestorsHub NewsWire - 10/18/2021 2:53:43 PM
Shares Jump as Firm Launches CBD Sleep Aid AllPennyStocks.com - 10/18/2021 11:52:00 AM
PAOG Introduces RelaxRX CBD Targeting $100 Billion Sleep Aid Market InvestorsHub NewsWire - 10/18/2021 10:06:45 AM
PAOG Cites New British Medical Journal Case Report On CBD Lung Cancer And COPD Treatment As Validation Of PAOG Ongoing RespRx Drug Research InvestorsHub NewsWire - 10/15/2021 9:36:18 AM
Investment in CBD Nutraceuticals Paying Off AllPennyStocks.com - 10/14/2021 3:36:00 PM
PAOG Announces Imminent Launch Of First CBD Nutraceutical Product Line - Q4 Sales Projected With Rapid Revenue Growth Anticipated To Follow InvestorsHub NewsWire - 10/12/2021 11:53:47 AM
PAOG Ships First CBD Nutraceutical Product To Distributor Entering $16 Billion Market InvestorsHub NewsWire - 10/7/2021 11:46:58 AM
PURA Farmersville Hemp Brand Timed To Catch Wave Of Celebrity Support InvestorsHub NewsWire - 10/6/2021 2:22:06 PM
PURA, USMJ, PAOG and PJET Momentum Builds On Technical Milestones InvestorsHub NewsWire - 10/5/2021 1:21:49 PM
PJET - A New Opportunity Taking Flight Soon InvestorsHub NewsWire - 10/5/2021 10:43:11 AM
PAOG To Build On CBD Business Through Acquisition InvestorsHub NewsWire - 10/5/2021 10:42:28 AM
PAOG plans expansion through to complement existing CBD business Seeking Alpha - 10/4/2021 11:41:03 AM
Futures1   Thursday, 05/10/18 01:20:59 AM
Re: None
Post # of 84172 
No big investors will ever put any money in
this penny stock like hedge funds etc..
The reason..#1. is 51% of any profits will go to
a shell company owned by the CEO.. this is
probably before any expenses.. #2 all voting rights go
to the 51% holder.. to sell it at any price or add more
more stock to dilute it even worse..
All this before a proof of concept., meaning show
me the $$$..
And the Company cannot say what it’s plans
are for the future...because it changes ever few months..




Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences